Characterization of the gut microbiome in Alzheimer disease and mild cognitive impairment among older adults in Uganda: A case-control studyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This case-control study characterized the gut microbiome in older adults with Alzheimer disease (AD) and mild cognitive impairment (MCI), comparing them to cognitively normal controls. Researchers extracted DNA from fecal samples and sequenced PCR products using Nanopore technology. They applied diversity indices, principal coordinate analysis, PERMANOVA, and LEfSe to identify microbial differences among the three groups. The study aimed to determine whether gut microbiome composition and diversity differ across the cognitive spectrum from healthy aging to dementia.
Who was studied?
The study recruited 104 participants aged 60 years and older from urban and rural populations in Uganda. Participants were categorized into AD, MCI, and control groups based on Montreal Cognitive Assessment (MoCA) scores and ICD-11/DSM-V diagnostic criteria. This design allowed comparison of gut microbiome features across a spectrum of cognitive status within an African population, a group underrepresented in prior microbiome-dementia research.
What were the most important findings?
Gut microbiome diversity, measured by the Chao1 and Shannon indices, was significantly reduced in patients with AD compared to the other groups. This reduced diversity aligns with prior findings that AD is associated with altered abundance of specific microbial taxa. The abstract text provided ends before detailing which specific taxa were enriched or depleted in the AD group, so those specifics cannot be reported here.
What are the greatest implications of this study?
The findings support the idea that reduced gut microbial diversity is linked to Alzheimer disease and may reflect disruption of the gut-brain axis, including increased intestinal permeability, systemic inflammation, and oxidative stress. Because this research was conducted in Uganda, it extends microbiome-dementia evidence to an African population, broadening the generalizability of prior findings from other regions. These results reinforce the potential of gut microbiome diversity as a marker of neurodegenerative risk and support further investigation into the microbiome as a target for aging-related cognitive health interventions.